Emerging efforts for discovering new biomarkers of liver disease and hepatotoxicity-Reference-Cited by-同舟云学术

Emerging efforts for discovering new biomarkers of liver disease and hepatotoxicity

Published:2014-02 Issue:2 Volume:8 Page:143-146
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

Hong Huixiao¹,Tong Weida¹

Affiliation:

1. Division of Bioinformatics & Biostatistics, National Center for Toxicological Research, US Food & Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA.

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

Link

https://www.futuremedicine.com/doi/pdf/10.2217/bmm.13.156

Reference20 articles.

1. Molecular biomarkers: a US FDA effort

2. Biomarkers for drug-induced liver injury

3. Causality assessment in hepatotoxicity by drugs and dietary supplements

4. Etiologies of Acute Liver Failure

5. Serum Metabolomics Reveals Irreversible Inhibition of Fatty Acid β-Oxidation through the Suppression of PPARα Activation as a Contributing Mechanism of Acetaminophen-Induced Hepatotoxicity

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconstitution of human tissue barrier function for precision and personalized medicine;Lab on a Chip;2024

2. Quality Control and Multi-targeted Therapeutic Approach of Nyctanthes arbor-tristris for Management of Hepatic Disease and Associated Complications;Pharmacognosy Magazine;2023-09-27

3. Quantitative Structure–Activity Relationship Models for Predicting Risk of Drug-Induced Liver Injury in Humans;Methods in Pharmacology and Toxicology;2018

4. A proteomic approach of biomarker candidate discovery for alcoholic liver cirrhosis;Journal of Circulating Biomarkers;2018-01

5. Evolution of proteomic biomarker for chronic liver disease;Journal of Circulating Biomarkers;2018-01